Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 201

1.

Availability, price and affordability of cardiovascular medicines: a comparison across 36 countries using WHO/HAI data.

van Mourik MS, Cameron A, Ewen M, Laing RO.

BMC Cardiovasc Disord. 2010 Jun 9;10:25. doi: 10.1186/1471-2261-10-25.

2.

Mapping the availability, price, and affordability of antiepileptic drugs in 46 countries.

Cameron A, Bansal A, Dua T, Hill SR, Moshe SL, Mantel-Teeuwisse AK, Saxena S.

Epilepsia. 2012 Jun;53(6):962-9. doi: 10.1111/j.1528-1167.2012.03446.x. Epub 2012 Mar 20.

3.

Measuring access to medicines: a survey of prices, availability and affordability in Shaanxi province of China.

Jiang M, Yang S, Yan K, Liu J, Zhao J, Fang Y.

PLoS One. 2013 Aug 1;8(8):e70836. doi: 10.1371/journal.pone.0070836. Print 2013.

4.

Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis.

Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R.

Lancet. 2009 Jan 17;373(9659):240-9. doi: 10.1016/S0140-6736(08)61762-6. Epub 2008 Nov 29. Erratum in: Lancet. 2009 Feb 21;373(9664):632.

PMID:
19042012
5.

The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries.

Mendis S, Fukino K, Cameron A, Laing R, Filipe A Jr, Khatib O, Leowski J, Ewen M.

Bull World Health Organ. 2007 Apr;85(4):279-88.

6.

Prices, availability and affordability of essential medicines in rural areas of Hubei Province, China.

Yang H, Dib HH, Zhu M, Qi G, Zhang X.

Health Policy Plan. 2010 May;25(3):219-29. doi: 10.1093/heapol/czp056. Epub 2009 Dec 1.

PMID:
19955093
7.

The availability, pricing and affordability of three essential asthma medicines in 52 low- and middle-income countries.

Babar ZU, Lessing C, Mace C, Bissell K.

Pharmacoeconomics. 2013 Nov;31(11):1063-82. doi: 10.1007/s40273-013-0095-9.

PMID:
24127259
8.

Prices & availability of common medicines at six sites in India using a standard methodology.

Kotwani A, Ewen M, Dey D, Iyer S, Lakshmi PK, Patel A, Raman K, Singhal GL, Thawani V, Tripathi S, Laing R.

Indian J Med Res. 2007 May;125(5):645-54.

PMID:
17642500
9.

Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases.

Ewen M, Zweekhorst M, Regeer B, Laing R.

PLoS One. 2017 Feb 7;12(2):e0171284. doi: 10.1371/journal.pone.0171284. eCollection 2017.

10.

Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China.

Fang Y, Wagner AK, Yang S, Jiang M, Zhang F, Ross-Degnan D.

Lancet Glob Health. 2013 Oct;1(4):e227-37. doi: 10.1016/S2214-109X(13)70072-X. Epub 2013 Sep 24.

11.
12.

Price, availability and affordability of medicines.

Mhlanga BS, Suleman F.

Afr J Prim Health Care Fam Med. 2014 Jun 24;6(1):E1-6. doi: 10.4102/phcfm.v6i1.604.

13.

Is the Brazilian pharmaceutical policy ensuring population access to essential medicines?

Bertoldi AD, Helfer AP, Camargo AL, Tavares NU, Kanavos P.

Global Health. 2012 Mar 21;8:6. doi: 10.1186/1744-8603-8-6.

14.

Access to paediatric essential medicines: a survey of prices, availability, affordability and price components in Shaanxi Province, China.

Wang X, Fang Y, Yang S, Jiang M, Yan K, Wu L, Lv B, Shen Q.

PLoS One. 2014 Mar 3;9(3):e90365. doi: 10.1371/journal.pone.0090365. eCollection 2014.

15.
16.

A national survey on availability, price and affordability of selected essential medicines for non communicable diseases in Sri Lanka.

Dabare PR, Wanigatunge CA, Beneragama BH.

BMC Public Health. 2014 Aug 8;14:817. doi: 10.1186/1471-2458-14-817.

17.

Quantifying the impoverishing effects of purchasing medicines: a cross-country comparison of the affordability of medicines in the developing world.

Niƫns LM, Cameron A, Van de Poel E, Ewen M, Brouwer WB, Laing R.

PLoS Med. 2010 Aug 31;7(8). pii: e1000333. doi: 10.1371/journal.pmed.1000333.

18.

Prices of antihypertensive medicines in sub-Saharan Africa and alignment to WHO's model list of essential medicines.

Twagirumukiza M, Annemans L, Kips JG, Bienvenu E, Van Bortel LM.

Trop Med Int Health. 2010 Mar;15(3):350-61. doi: 10.1111/j.1365-3156.2009.02453.x. Epub 2010 Jan 11.

19.

The prices people pay for medicines in Zimbabwe.

Gavaza P, Simoyi T, Makunike B, Maponga CC.

Cent Afr J Med. 2009 Jan-Apr;55(1-4):14-9.

PMID:
21977842
20.

Switching from originator brand medicines to generic equivalents in selected developing countries: how much could be saved?

Cameron A, Mantel-Teeuwisse AK, Leufkens HG, Laing RO.

Value Health. 2012 Jul-Aug;15(5):664-73. doi: 10.1016/j.jval.2012.04.004. Epub 2012 Jul 11.

Supplemental Content

Support Center